QSAM Biosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - USD ($)				1 Months Ended	9 Months Ended
SUBSEQUENT EVENTS (Details) - USD ($)	Apr. 29, 2016	Sep. 23, 2015	Jul. 02, 2014	Mar. 31, 2017	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2015	Jun. 13, 2016	Jan. 31, 2016	Jan. 08, 2016	Dec. 31, 2015
Subsequent Event [Line Items]
Principal amount			$ 435,500			$ 165,000			$ 105,000		$ 435,750
Convertible debt amount						$ 270,750
Interest rate										6.00%
Exercise price of warrants		$ 0.21	$ 2.45			$ 0.50	$ 0.21
Extended maturity date		Jul. 31, 2016	Mar. 31, 2015
Amount paid to employees						$ 117,000	$ 100,089
Convertible Notes [Member]
Subsequent Event [Line Items]
Sale of common stock, value						75,000
Short-term debt, term	6 months
Principal amount	$ 60,200							$ 16,667
Convertible debt amount	$ 1,000,000
Interest rate	8.00%
Original issuance discount (as a percent)	10.00%
Face amount of debt	$ 66,000							$ 15,000
Conversion price	$ 0.26
New cash investment						75,000
Proceeds from conversion of notes and advances						$ 156,368
Subsequent Event [Member]
Subsequent Event [Line Items]
Convertible debt amount				$ 1,500,000
Interest rate				8.00%
Face amount of debt				$ 1,000,000
Conversion price				$ 0.15
Exercise price of warrants				$ 0.50
Extended maturity date				Jul. 31, 2017
Liability restructured				$ 800,000
Additional payables and contract liabilities				200,000
Subsequent Event [Member] \| Former Employees [Member]
Subsequent Event [Line Items]
Liability restructured				189,449
Amount paid to employees				$ 52,123
Restricted common stock				915,506
Subsequent Event [Member] \| Chief Executive Officer [Member]
Subsequent Event [Line Items]
Issuance of shares for consulting agreement, shares				$ 5,000,000
Exclusivity period to negotiate terms of acquisition				18 months
Financing costs				$ 3,000,000
Liability restructured				$ 112,797
Restricted common stock				666,667
Deferred salary				$ 100,000
Employment agreement				10,000
Base salary per year				220,000
Subsequent Event [Member] \| Board of Director [Member]
Subsequent Event [Line Items]
Financing costs				156,368
Subsequent Event [Member] \| Previously Affiliated Shareholder [Member]
Subsequent Event [Line Items]
Financing costs				11,784
Subsequent Event [Member] \| Chairman [Member]
Subsequent Event [Line Items]
Issuance of shares for consulting agreement, shares				$ 10,000,000
Exclusivity period to negotiate terms of acquisition				12 months
Financing costs				$ 3,000,000
Employment agreement				12,500
Base salary per year				350,000
Subsequent Event [Member] \| Over-Allotment Option [Member]
Subsequent Event [Line Items]
Face amount of debt				$ 500,000
Subsequent Event [Member] \| Convertible Notes [Member]
Subsequent Event [Line Items]
Sale of common stock, value					$ 75,000
Short-term debt, term				36 months
Convertible debt amount				$ 165,000
Interest rate				15.00%
Original issuance discount (as a percent)				50.00%
Extended maturity date				Dec. 31, 2017
Conversion valuation closing amount				$ 5,000,000
Conversion valuation ceiling amount				12,000,000
Conversion valuation floor amount				$ 6,000,000
New cash investment					75,000
Proceeds from conversion of notes and advances					$ 156,368